Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccination Adverse Event”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Not applicableStudy completedNCT05438472
What this trial is testing

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

Who this might be right for
Myocarditis
University Hospital, Basel, Switzerland 835
Not applicableStudy completedNCT03057483
What this trial is testing

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute

Who this might be right for
Influenza Vaccines
Butantan Institute 533
Early research (Phase 1)Study completedNCT00164411
What this trial is testing

Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

Who this might be right for
Pneumococcal Infections
Centers for Disease Control and Prevention 30
Not applicableStudy completedNCT01318876
What this trial is testing

Surveillance for Adverse Events Following Influenza Immunization

Who this might be right for
InfluenzaVaccines Adverse Reaction
PHAC/CIHR Influenza Research Network 7,645
Not applicableStudy completedNCT05113472
What this trial is testing

Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

Who this might be right for
Adverse Drug Event
Respiralab 1,291
Post-approval studies (Phase 4)UnknownNCT03965195
What this trial is testing

Recombinant Influenza Vaccination in U.S. Nursing Homes

Who this might be right for
InfluenzaInfluenza -Like IllnessInfluenza, Human
Insight Therapeutics, LLC 1,989
Post-approval studies (Phase 4)Study completedNCT00244673
What this trial is testing

Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination

Who this might be right for
MortalityHospitalizationAdverse Events
Bandim Health Project 6,534
Not applicableStudy completedNCT02133456
What this trial is testing

A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older

Who this might be right for
InfluenzaVaccination Adverse Event
Centers for Disease Control and Prevention, China 166,240
Not applicableStudy completedNCT05794113
What this trial is testing

Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform

Who this might be right for
Mobile AppsImmunizationAdverse Event Following Immunisation
The Ottawa Hospital 2,408
Post-approval studies (Phase 4)Study completedNCT02521974
What this trial is testing

Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children

Who this might be right for
Adverse Event Following Immunisation
Fidec Corporation 164
Not applicableStudy completedNCT02133469
What this trial is testing

PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae

Who this might be right for
Streptococcal PneumoniaNasopharyngeal DiseasesVaccination Adverse Event
Centers for Disease Control and Prevention, China 3,281
Post-approval studies (Phase 4)Study completedNCT03654937
What this trial is testing

Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes

Who this might be right for
Influenza Virus Vaccine Adverse ReactionInfluenza Vaccine Allergy
Universität des Saarlandes 45
Post-approval studies (Phase 4)Study completedNCT03969641
What this trial is testing

Safety of RIV4 Versus IIV4 in Pregnant Women

Who this might be right for
SafetyAdverse Event Following ImmunisationBirth Outcomes
Duke University 384
Post-approval studies (Phase 4)Study completedNCT06503900
What this trial is testing

Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study

Who this might be right for
Birth OutcomesSafetyAdverse Event Following Immunization
Duke University 98
Not applicableUnknownNCT03938597
What this trial is testing

Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers

Who this might be right for
Drug-Related Side Effects and Adverse Reactions
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 10
Post-approval studies (Phase 4)Study completedNCT01807780
What this trial is testing

Safety, Immunogenicity And Efficacy Of Vaccination In Military Personnel

Who this might be right for
Vaccination Adverse EventsVaccination FailureSpecific Antibody Response
University of Roma La Sapienza 262
Post-approval studies (Phase 4)Looking for participantsNCT07485283
What this trial is testing

Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia

Who this might be right for
Cardiovascular DiseaseDementia
Tor Biering-Sørensen 162,000
Not applicableStudy completedNCT03671369
What this trial is testing

A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Who this might be right for
Neoplasms, Rectal
GlaxoSmithKline 670
Not applicableUnknownNCT05033613
What this trial is testing

Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease

Who this might be right for
PainFatigueHeadache+4 more
National Taiwan University Hospital 1,500
Early research (Phase 1)UnknownNCT02075983
What this trial is testing

Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes

Who this might be right for
HIV
Imperial College London 30
Load More Results